PEP-Galzelka-Incidence-of-clinically-significant-percutaneous
Use of off label or drugs beyond licence in pain medicine
This document explores the clinical and legal implications of off-label and unlicensed drug use in medicine, specifically focusing on the role of pain medicine practitioners. It discusses the challenges and responsibilities associated with prescribing medications outside of th...
Reg 37 - Training in anaesthesia leading to FANZCA, and accreditation of facilities to deliver this
Regulation 37 - Training in anaesthesia leading to FANZCA, and accreditation of facilities to deliver this curriculum.
ANZCA feedback on AHPRA cosmetic surgery consultation
21 April 2022 letter to Andrew Brown
Independent Reviewer of the regulation of health practitioners in cosmetic surgery
c/o Ahpra
User guide for PEP supervisors and co-supervisors
A user guide to the ePortfolio platform for Procedures Endorsement Program supervisors
ANZCA Pholcodine Statement September 2023
This statement has been prepared in response to the decision of the Australian Government
Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...
FPM SOT nomination form
Faculty of Pain Medicine supervisor of training nomination form.
Unconfirmed_2023-May-AGM-minutes_final
AGM 2023 May AGM minutes
Peer review of practice (procedures in pain medicine) - guideline
Peer review of practice (procedures in pain medicine) - guideline
ANZCA Concession application form